XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stockholders' Equity Note [Abstract] |
Summary of Stock Option Activity | A summary of stock option activity under the plans during the years ended December 31, 2024 and 2023, are as follows:
|  | Stock Options Outstanding |
|  | Number of Underlying Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Aggregate Intrinsic Value |
Outstanding on January 1, 2023 |  |  | 970,680 |  |  | $ | 2.07 |  |  |  | 5.61 |  |  | $ | 988,197 |
Granted |  |  | 400,000 |  |  | $ | 2.95 |  |  |  | - |  |  | $ | - |
Forfeited / Canceled |  |  | (8,250 | ) |  | $ | 2.49 |  |  |  | - |  |  | $ | - |
Exercised |  |  | (38,670 | ) |  | $ | 0.63 |  |  |  | - |  |  | $ | - |
Outstanding on December 31, 2023 |  |  | 1,323,760 |  |  | $ | 2.37 |  |  |  | 4.06 |  |  | $ | 169,802 |
Granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited / Canceled |  |  | (99,784 | ) |  | $ | 1.56 |  |  |  | - |  |  | $ | 181,779 |
Exercised |  |  | (83,426 | ) |  | $ | 1.76 |  |  |  | - |  |  | $ | 132,627 |
Outstanding on December 31, 2024 |  |  | 1,140,550 |  |  | $ | 2.49 |  |  |  | 3.85 |  |  | $ | 1,019,680 |
Exercisable on December 31, 2024 |  |  | 890,550 |  |  | $ | 2.36 |  |  |  | 2.56 |  |  | $ | 919,680 |
Vested and expected to vest on December 31, 2024 |  |  | 890,550 |  |  | $ | 2.36 |  |  |  | 2.56 |  |  | $ | 919,680 |
Summary of Common Stock Options Outstanding | The following table summarizes information about common stock options outstanding as of December 31, 2024:
|  |  |  | Stock Options Outstanding |  |  | Stock Options Exercisable |
Plan |  | Exercise Price Range |  | Number of Shares Outstanding |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |  |  | Number of Shares Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
2015 |  | $1.08-$1.95 |  |  | 197,059 |  |  |  | 2.04 |  |  | $ | 1.75 |  |  |  | 197,059 |  |  |  | 2.04 |  |  | $ | 1.75 |
2017 |  | $2.14-$4.09 |  |  | 543,491 |  |  |  | 1.13 |  |  | $ | 2.42 |  |  |  | 543,491 |  |  |  | 1.13 |  |  | $ | 2.42 |
Incentive options issued outside of Plans |  | 2.95 |  |  | 400,000 |  |  |  | 8.43 |  |  | $ | 2.95 |  |  |  | 150,000 |  |  |  | 8.43 |  |  | $ | 2.95 |
|  |  |  |  | 1,140,550 |  |  |  |  |  |  |  |  |  | 890,550 |  |  |  |  |  |  |
Schedule of Assumption to Calculate Weighted Average Grant Date Fair Value of Options Grant | The following table presents details of the assumptions used to calculate the weighted-average grant date fair value of common stock options granted by the Company. There were no options granted during the year ended December 31, 2024.
|  | For the Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Expected term (in years) |  |  | - |  |  |  | 6.16 |
Expected volatility |  |  | 0.00 | % |  |  | 72.73 | %
Risk-free interest rate |  |  | 0.00 | % |  |  | 3.79 | %
Weighted average grant date fair value per share |  | $ | - |  |  | $ | 2.95 |
Grant date fair value of options vested |  | $ | 1,107,251 |  |  | $ | 927,447 |
Intrinsic value of options exercised |  | $ | 132,627 |  |  | $ | 48,361 |
Schedule of Restricted Stock Unit Activity | The Company’s restricted stock unit activity for the years ended December 31, 2024 and 2023, was as follows:
|  | Restricted Stock Units |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Unvested on January 1, 2023 |  |  | 907,507 |  |  | $ | 4.05 |
Granted |  |  | 925,243 |  |  | $ | 2.80 |
Vested |  |  | (647,943 | ) |  | $ | 3.94 |
Canceled |  |  | (91,318 | ) |  | $ | 4.30 |
Unvested on December 31, 2023 |  |  | 1,093,489 |  |  | $ | 3.04 |
Granted |  |  | 654,700 |  |  | $ | 1.81 |
Vested |  |  | (495,510 | ) |  | $ | 3.16 |
Canceled |  |  | (124,252 | ) |  | $ | 1.99 |
Unvested on December 31, 2024 |  |  | 1,128,427 |  |  | $ | 3.04 |
Summary of Stock-Based Compensation Expense | Stock-based compensation expense for the years ended December 31, 2024 and 2023, was comprised of the following:
|  | For the Year Ended December 31, |
Stock-based compensation classified as: |  | 2024 |  |  | 2023 |
General and administrative |  | $ | 1,296,977 |  |  | $ | 1,452,774 |
Production |  |  | 141,040 |  |  |  | 305,763 |
Marketing and selling |  |  | 334,795 |  |  |  | 322,854 |
Research and development |  |  | 215,314 |  |  |  | 263,967 |
|  | $ | 1,988,125 |  |  | $ | 2,345,358 |
Schedule of Warrant Activity | The following table summarizes the Company’s warrant activity during the years ended December 31, 2024 and 2023:
|  | Number of Warrants |  |  | Weighted Average Exercise Price |
Warrants outstanding on December 31, 2022 |  |  | 451,112 |  |  | $ | 5.37 |
Warrants granted |  |  | - |  |  | $ | - |
Warrants expired |  |  | (380,000 | ) |  | $ | 6.00 |
Warrants exercised |  |  | (28,090 | ) |  | $ | 1.78 |
Warrants outstanding on December 31, 2023 |  |  | 43,022 |  |  | $ | 2.15 |
Warrants expired |  |  | (9,302 | ) |  | $ | 2.15 |
Warrants exercised |  |  | (33,720 | ) |  | $ | 2.15 |
Warrants outstanding on December 31, 2024 |  |  | - |  |  | $ | - |

X
- Definition Summary of stock based compensation expense. + References No definition available. + Details
Name: | oss_SummaryOfStockBasedCompensationExpenseTableTextBlock
Namespace Prefix: | oss_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration